Lexicon Pharmaceuticals
LXRX
#6051
Rank
โ‚น99.32 B
Marketcap
โ‚น223.60
Share price
-4.51%
Change (1 day)
393.75%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -โ‚น5.92 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น70.86 Million. In 2024 the company made an earning of -โ‚น19.24 Billion a decrease over its 2023 earnings that were of -โ‚น17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น5.92 Billion-69.25%
2024 -โ‚น19.24 Billion13.15%
2023 -โ‚น17 Billion73.74%
2022 -โ‚น9.79 Billion16.16%
2021 -โ‚น8.43 Billion49.82%
2020 -โ‚น5.63 Billion-147.19%
2019 โ‚น11.91 B-203.42%
2018 -โ‚น11.52 Billion-15.31%
2017 -โ‚น13.6 Billion0.2%
2016 -โ‚น13.58 Billion2920.7%
2015 -โ‚น0.45 Billion-95.33%
2014 -โ‚น9.64 Billion-3.61%
2013 -โ‚น10 Billion-5.52%
2012 -โ‚น10.58 Billion-4.17%
2011 -โ‚น11.04 Billion15.5%
2010 -โ‚น9.56 Billion8.36%
2009 -โ‚น8.82 Billion-4.81%
2008 -โ‚น9.27 Billion28.79%
2007 -โ‚น7.2 Billion35.71%
2006 -โ‚น5.31 Billion52.91%
2005 -โ‚น3.47 Billion-23.89%
2004 -โ‚น4.56 Billion-24.19%
2003 -โ‚น6.01 Billion-0.48%
2002 -โ‚น6.04 Billion44.12%
2001 -โ‚น4.19 Billion23.01%
2000 -โ‚น3.41 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น712.25 B-10,922.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น111.31 B-1,791.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น494.88 B-7,619.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น51.5 Billion 682.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น15.70 B-338.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.64 Billion-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.24 Billion-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น37.00 B-662.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น0.92 Billion-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA